Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions. Academic Article uri icon

Overview

abstract

  • BACKGROUND: The landscape of guided bronchoscopy for the sampling of pulmonary parenchymal lesions is evolving rapidly. Shape-sensing robotic-assisted bronchoscopy (ssRAB) recently was introduced as means to allow successful sampling of traditionally challenging lesions. RESEARCH QUESTION: What are the feasibility, diagnostic yield, determinants of diagnostic sampling, and safety of ssRAB in patients with pulmonary lesions? STUDY DESIGN AND METHODS: Data from 131 consecutive ssRAB procedures performed at a US-based cancer center between October 2019 and July 2020 were captured prospectively and analyzed retrospectively. Definitions of diagnostic procedures were based on prior standards. Associations of procedure- and lesion-related factors with diagnostic yield were examined by univariate and multivariate generalized linear mixed models. RESULTS: A total of 159 pulmonary lesions were targeted during 131 ssRAB procedures. The median lesion size was 1.8 cm, 59.1% of lesions were in the upper lobe, and 66.7% of lesions were beyond a sixth-generation airway. The navigational success rate was 98.7%. The overall diagnostic yield was 81.7%. Lesion size of ≥ 1.8 cm and central location were associated significantly with a diagnostic procedure in the univariate analysis. In the multivariate model, lesions of ≥ 1.8 cm were more likely to be diagnostic compared with lesions < 1.8 cm, after adjusting for lung centrality (OR, 12.22; 95% CI, 1.66-90.10). The sensitivity and negative predictive value of ssRAB for primary thoracic malignancies were 79.8% and 72.4%, respectively. The overall complication rate was 3.0%, and the pneumothorax rate was 1.5%. INTERPRETATION: This study was the first to provide comprehensive evidence regarding the usefulness and diagnostic yield of ssRAB in the sampling of pulmonary parenchymal lesions. ssRAB may represent a significant advancement in the ability to access and sample successfully traditionally challenging pulmonary lesions via the bronchoscopic approach, while maintaining a superb safety profile. Lesion size seems to remain the major predictor of a diagnostic procedure.

authors

  • Kalchiem-Dekel, Or
  • Connolly, James
  • Lin, I-Hsin
  • Husta, Bryan C
  • Adusumilli, Prasad S
  • Beattie, Jason A
  • Buonocore, Darren J
  • Dycoco, Joseph
  • Fuentes, Paige
  • Jones, David R
  • Lee, Robert P
  • Park, Bernard J
  • Rocco, Gaetano
  • Chawla, Mohit
  • Bott, Matthew J

publication date

  • August 9, 2021

Research

keywords

  • Bronchoscopy
  • Lung Neoplasms
  • Robotics

Identity

PubMed Central ID

  • PMC8941601

Scopus Document Identifier

  • 85122629489

Digital Object Identifier (DOI)

  • 10.1016/j.chest.2021.07.2169

PubMed ID

  • 34384789

Additional Document Info

volume

  • 161

issue

  • 2